The UK government yesterday announced that they are contributing an additional £200 million to the Research Partnership Investment Fund to boost scientific research. As a result of the government support increasing to £300 million, the total investment is estimated to be a minimum of £1 billion, ministers claim. The government support has been increased since
Drugs developed to treat rare diseases have the potential to produce as much lifetime revenue as medication used for more common health conditions, according to a study published by Thomson Reuters yesterday. The report compared the total value of orphan drugs from 1990 to 2030 and found that government incentives, shorter clinical trials and high
Analysts at Peel Hunt have analysed the global healthcare sector, and stated that it is in a fairly healthy condition, in spite of the pressures the industry is currently under. Contained within the report, the broker claims that the healthcare sector “has again proved its resilience in periods of economic uncertainty.” They quote the Dow
